Dialysis Perspective

 
 
  • Myeloma-Induced Acute Kidney Injury: Medicine vs Machine Higher-tech or more aggressive treatment doesn't necessarily mean better, cautions Tejas Desai, MD, in his review of studies on treatment strategies for myeloma-induced acute kidney injury.
  • Solutions for Diabetic Ketoacidosis: Finding the Right Balance Can findings in adult patients with sepsis be extrapolated to children with DKA? Studies in pediatric patients give this nephrologist pause.
  • The Kidney and COVID-19: What We Know so Far   Nephrologists Matthew Sparks and Samira Farouk, of the Freely Filtered podcast, discuss the kidney effects of COVID-19 -- what is and isn't clear in patients with and without preexisting kidney disease.
  • Patient on Dialysis? The PCP's Role   The Curbsiders share the pearls they gleaned from speaking with nephrology guru Dr Joel Topf, fondly known as 'Kidney Boy.'
  • ERA-EDTA 2020 Read clinically focused news coverage of key developments from ERA-EDTA 2020
  • Bellevue Starts to Reopen After COVID Peak   After a month that felt like years, Bellevue hospital staff are starting to reform their daily routines in a changed world. Dr Danielle Ofri shares her insights.
  • COVID-19: Don't Forget About Plasmapheresis The strategy to filter out virions from infected plasma has been tested with the Middle East respiratory syndrome coronavirus. Why not consider it for SARS-CoV2, asks nephrologist Tejas Desai.
  • Nephrologist #COVIDWarrior: 'We Are Winning Some of These Battles' After 2 weeks on the frontlines of Detroit treating COVID-19 patients, nephrologist Joel Topf provides a rundown on his clinical observations.
  • NKF 2020 Read clinically focused news coverage of key developments from NKF 2020
  • Is Patient Race Important -- Or Just Convenient?   Every clinical presentation begins with the patient's age, race, and gender. But what does race really tell us?
  • ISN 2020 Read clinically focused news coverage of key developments from ISN 2020
  • Cardios, Nephros, PCPs -- We're All Diabetologists Now Newer diabetes medications are proving effective in reducing CV events, hospitalizations for heart failure, and progression to dialysis. So where do these drugs belong?
  • ACIP 2020 Child/Teen Immunization Schedule: The Highlights A quick tour of key changes in the 2020 ACIP child/adolescent immunization schedule.
  • 'Frustration and Disbelief' Over Drug Shortages   Drs Robert Glatter and Paul Biddinger discuss drug shortages, including potential causes and solutions.
  • Dialysis Industry Mergers: Profits Rise as Outcomes Worsen An economic analysis of the dialysis industry shows how the usual benefits of mergers are negated in the healthcare industry by imprudent financial incentives and lack of true competitive market forces.
  • Palliative Care in End-Stage Renal Disease In this case, a social worker must respond to a patient who expresses that she would like to discontinue dialysis and knows that doing so means she will die soon.
  • Highlights From ASN Kidney Week 2019   Highlights from ASN's Kidney Week 2019 include results from the CREDENCE trial showing benefit from the SGLT2 inhibitor canagliflozin for patients with established diabetic nephropathy.
  • ISCHEMIA-CKD PI Hopes Study Doesn't Fuel the Flames of Renalism   Principal investigator Sripal Bangalore discusses ISCHEMIA-CKD and its implications for the management of patients with chronic kidney disease and stable CAD.
  • For-Profit Dialysis Units Referring Less for Transplant?   A recent study shows that patients at for-profit dialysis units are less likely to be placed on the transplant waitlist than patients at non-profit units. What's going on?
  • Trump Should Get Kudos for Looking at Kidney Dialysis, Transplant   Dr Art Caplan discusses President Trump's ideas regarding re-examination of dialysis and kidney transplant in the US, and the need to improve access to immunosuppressive drugs post-transplant.